Switch to:
Also traded in: Brazil, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.91
NYSE:AET's Cash-to-Debt is ranked lower than
64% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.15 vs. NYSE:AET: 0.91 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:AET' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.14  Med: 0.48 Max: No Debt
Current: 0.91
0.14
No Debt
Equity-to-Asset 0.30
NYSE:AET's Equity-to-Asset is ranked lower than
74% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.38 vs. NYSE:AET: 0.30 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:AET' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.06  Med: 0.2 Max: 0.3
Current: 0.3
0.06
0.3
Debt-to-Equity 0.47
NYSE:AET's Debt-to-Equity is ranked higher than
53% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.59 vs. NYSE:AET: 0.47 )
Ranked among companies with meaningful Debt-to-Equity only.
NYSE:AET' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.14  Med: 0.25 Max: 1.24
Current: 0.47
0.14
1.24
Debt-to-EBITDA 1.38
NYSE:AET's Debt-to-EBITDA is ranked lower than
61% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.82 vs. NYSE:AET: 1.38 )
Ranked among companies with meaningful Debt-to-EBITDA only.
NYSE:AET' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.31  Med: 1.61 Max: 3.92
Current: 1.38
1.31
3.92
Beneish M-Score: -1.95
WACC vs ROIC
6.42%
22.06%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Net Margin % 5.77
NYSE:AET's Net Margin % is ranked lower than
56% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.87 vs. NYSE:AET: 5.77 )
Ranked among companies with meaningful Net Margin % only.
NYSE:AET' s Net Margin % Range Over the Past 10 Years
Min: 3.15  Med: 4.05 Max: 5.88
Current: 5.77
3.15
5.88
ROE % 21.79
NYSE:AET's ROE % is ranked lower than
69% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.89 vs. NYSE:AET: 21.79 )
Ranked among companies with meaningful ROE % only.
NYSE:AET' s ROE % Range Over the Past 10 Years
Min: 11.38  Med: 15.41 Max: 19.85
Current: 21.79
11.38
19.85
ROA % 6.11
NYSE:AET's ROA % is ranked lower than
61% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.25 vs. NYSE:AET: 6.11 )
Ranked among companies with meaningful ROA % only.
NYSE:AET' s ROA % Range Over the Past 10 Years
Min: 3.06  Med: 4.05 Max: 5.2
Current: 6.11
3.06
5.2
3-Year Revenue Growth Rate 3.80
NYSE:AET's 3-Year Revenue Growth Rate is ranked lower than
74% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.60 vs. NYSE:AET: 3.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:AET' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -15.7  Med: 5.3 Max: 22
Current: 3.8
-15.7
22
3-Year EBITDA Growth Rate -0.20
NYSE:AET's 3-Year EBITDA Growth Rate is ranked lower than
85% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.70 vs. NYSE:AET: -0.20 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:AET' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -70.3  Med: -0.2 Max: 24.1
Current: -0.2
-70.3
24.1
GuruFocus has detected 4 Warning Signs with Aetna Inc NYSE:AET.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:AET's 30-Y Financials

Financials (Next Earnings Date: 2018-10-31)


Revenue & Net Income
Equity & Asset
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2017

AET Guru Trades in Q3 2017

Ray Dalio 11,904 sh (New)
Leon Cooperman 179,700 sh (New)
Paul Tudor Jones 13,663 sh (New)
George Soros 88,100 sh (New)
Caxton Associates 3,200 sh (New)
Steven Cohen 429,353 sh (+233.87%)
Joel Greenblatt 44,344 sh (+54.91%)
Lee Ainslie 14,020 sh (+22.23%)
Larry Robbins 3,794,484 sh (+14.62%)
Diamond Hill Capital 1,633,972 sh (+0.23%)
John Buckingham 82,109 sh (+0.19%)
Pioneer Investments 78,035 sh (unchged)
Jeff Auxier 5,307 sh (unchged)
Dodge & Cox 1,400 sh (unchged)
David Dreman 7,320 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 191,137 sh (unchged)
Richard Pzena Sold Out
Chris Davis 3,824,917 sh (-3.90%)
Vanguard Health Care Fund 4,646,623 sh (-8.91%)
Jim Simons 605,490 sh (-53.07%)
Jeremy Grantham 10,177 sh (-54.32%)
» More
Q4 2017

AET Guru Trades in Q4 2017

Leucadia National 163,000 sh (New)
Louis Moore Bacon 30,000 sh (New)
Daniel Loeb 1,850,000 sh (New)
John Paulson 50,000 sh (New)
Jeremy Grantham 318,700 sh (+3031.57%)
Pioneer Investments 926,948 sh (+1087.86%)
Paul Tudor Jones 109,000 sh (+697.78%)
Lee Ainslie 38,530 sh (+174.82%)
George Soros 199,000 sh (+125.88%)
Joel Greenblatt 46,880 sh (+5.72%)
Jeff Auxier 5,308 sh (+0.02%)
David Dreman 7,320 sh (unchged)
Dodge & Cox 1,400 sh (unchged)
Ray Dalio Sold Out
Jim Simons Sold Out
Leon Cooperman Sold Out
Caxton Associates Sold Out
Diamond Hill Capital 1,632,830 sh (-0.07%)
John Buckingham 78,411 sh (-4.50%)
Vanguard Health Care Fund 4,051,023 sh (-12.82%)
Chris Davis 3,255,479 sh (-14.89%)
Larry Robbins 2,869,460 sh (-24.38%)
Steven Cohen 4,200 sh (-99.02%)
Eaton Vance Worldwide Health Sciences Fund 154,756 sh (-19.03%)
» More
Q1 2018

AET Guru Trades in Q1 2018

Mario Gabelli 28,107 sh (New)
David Abrams 1,380,000 sh (New)
First Pacific Advisors 6,800 sh (New)
Jim Simons 803,790 sh (New)
Caxton Associates 8,546 sh (New)
John Paulson 164,300 sh (+228.60%)
George Soros 545,585 sh (+174.16%)
Paul Tudor Jones 154,958 sh (+42.16%)
Chris Davis 4,569,931 sh (+40.38%)
Diamond Hill Capital 1,715,322 sh (+5.05%)
Vanguard Health Care Fund 4,051,023 sh (unchged)
David Dreman 7,320 sh (unchged)
Jeff Auxier 5,308 sh (unchged)
Dodge & Cox 1,400 sh (unchged)
Lee Ainslie Sold Out
Louis Moore Bacon Sold Out
Daniel Loeb Sold Out
Steven Cohen Sold Out
Larry Robbins 2,834,217 sh (-1.23%)
John Buckingham 76,530 sh (-2.40%)
Leucadia National 158,141 sh (-2.98%)
Jeremy Grantham 257,680 sh (-19.15%)
Joel Greenblatt 32,967 sh (-29.68%)
Pioneer Investments 224,022 sh (-75.83%)
Eaton Vance Worldwide Health Sciences Fund 111,910 sh (-27.69%)
» More
Q2 2018

AET Guru Trades in Q2 2018

Andreas Halvorsen 268,035 sh (New)
Joel Greenblatt 70,627 sh (+114.24%)
John Paulson 280,300 sh (+70.60%)
Jeremy Grantham 425,000 sh (+64.93%)
Paul Tudor Jones 194,925 sh (+25.79%)
David Abrams 1,575,000 sh (+14.13%)
Larry Robbins 3,104,322 sh (+9.53%)
Mario Gabelli 28,297 sh (+0.68%)
Chris Davis 4,595,467 sh (+0.56%)
Vanguard Health Care Fund 4,051,023 sh (unchged)
Paul Tudor Jones 30,000 sh (unchged)
Dodge & Cox 1,400 sh (unchged)
First Pacific Advisors Sold Out
Caxton Associates Sold Out
Pioneer Investments 223,697 sh (-0.15%)
Diamond Hill Capital 1,706,452 sh (-0.52%)
John Buckingham 75,480 sh (-1.37%)
George Soros 512,928 sh (-5.99%)
Leucadia National 118,971 sh (-24.77%)
Eaton Vance Worldwide Health Sciences Fund 96,742 sh (-13.55%)
» More
» Details

Insider Trades

Latest Guru Trades with AET

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Chris Davis 2018-06-30 Add 0.56%0.02%$168.11 - $190.92 $ 196.9510%4,595,467
George Soros 2018-06-30 Reduce -5.99%0.1%$168.11 - $190.92 $ 196.9510%512,928
John Paulson 2018-06-30 Add 70.60%0.43%$168.11 - $190.92 $ 196.9510%280,300
Leucadia National 2018-06-30 Reduce -24.77%0.47%$168.11 - $190.92 $ 196.9510%118,971
Joel Greenblatt 2018-06-30 Add 114.24%0.1%$168.11 - $190.92 $ 196.9510%70,627
Mario Gabelli 2018-06-30 Add 0.68%$168.11 - $190.92 $ 196.9510%28,297
Chris Davis 2018-03-31 Add 40.38%0.96%$168.11 - $193.74 $ 196.9510%4,569,931
George Soros 2018-03-31 Add 174.16%1.08%$168.11 - $193.74 $ 196.9510%545,585
John Paulson 2018-03-31 Add 228.60%0.42%$168.11 - $193.74 $ 196.9510%164,300
Leucadia National 2018-03-31 Reduce -2.98%0.07%$168.11 - $193.74 $ 196.9510%158,141
Joel Greenblatt 2018-03-31 Reduce -29.68%0.04%$168.11 - $193.74 $ 196.9510%32,967
Mario Gabelli 2018-03-31 New Buy0.03%$168.11 - $193.74 $ 196.9510%28,107
Vanguard Health Care Fund 2017-12-31 Reduce -12.82%0.2%$151.44 - $182.73 $ 196.9515%4,051,023
Chris Davis 2017-12-31 Reduce -14.89%0.39%$151.44 - $182.73 $ 196.9515%3,255,479
George Soros 2017-12-31 Add 125.88%0.56%$151.44 - $182.73 $ 196.9515%199,000
Leucadia National 2017-12-31 New Buy2.25%$151.44 - $182.73 $ 196.9515%163,000
John Paulson 2017-12-31 New Buy0.18%$151.44 - $182.73 $ 196.9515%50,000
Joel Greenblatt 2017-12-31 Add 5.72%0.01%$151.44 - $182.73 $ 196.9515%46,880
Leon Cooperman 2017-12-31 Sold Out 1.11%$151.44 - $182.73 $ 196.9515%0
Vanguard Health Care Fund 2017-09-30 Reduce -8.91%0.15%$151.98 - $163.21 $ 196.9526%4,646,623
Chris Davis 2017-09-30 Reduce -3.90%0.1%$151.98 - $163.21 $ 196.9526%3,824,917
Leon Cooperman 2017-09-30 New Buy1.11%$151.98 - $163.21 $ 196.9526%179,700
George Soros 2017-09-30 New Buy0.42%$151.98 - $163.21 $ 196.9526%88,100
Joel Greenblatt 2017-09-30 Add 54.91%0.04%$151.98 - $163.21 $ 196.9526%44,344
Richard Pzena 2017-09-30 Sold Out 0.13%$151.98 - $163.21 $ 196.9526%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 524114    SIC: 6324
Compare:NYSE:ANTM, NYSE:CVS, NAS:ESRX, NYSE:CI, NYSE:HUM, NYSE:CNC, NYSE:WCG, NYSE:MOH, BSP:ODPV3, BSP:QUAL3, NAS:MGLN, XPAR:GDS, NAS:HIIQ, OSTO:MCOV B, ROCO:6665, ATH:IATR, ASX:ONT, TSXV:NAC, MIL:HI, OTCPK:HFRN » details
Traded in other countries:AETB34.Brazil, HE8.Germany,
Headquarter Location:USA
Aetna Inc is a diversified health care benefits company. The company offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health.

Aetna is one of the largest managed-care organizations in the U.S., with over 22 million medical members. This large member count helps the firm diversify its operating risk and has formed the basis for material competitive advantages. The firm provides health insurance services to its members through products that encompass every major insurance market--individual, group, and government sponsored. Aetna and CVS recently announced their intention to merge operations, and if approved, it would form one of the most powerful players within the healthcare space.

Top Ranked Articles about Aetna Inc

Wall Street Mostly Higher Wednesday 3D Systems skyrockets on earnings results
U.S. stock market indexes were initially trading in negative territory on Wednesday morning before reversing higher as the S&P 500 continues toward a record high, fueled by good corporate results. Read more...
George Soros' High-Conviction Picks The guru loaded up on shares of these three high-performers by as much as 500% over two consecutive quarters
George Soros (Trades, Portfolio)’ high-conviction stock picks in two consecutive quarters are among some of the best performers of the S&P 500. Read more...
CVS Is a Massive Bargain This is a long-term market beating opportunity with or without the Aetna acquisition
For the market to place a forward price multiple less than 10 on CVS Health Corp (NYSE:CVS) is absolutely foolish. Along with Walgreens (NASDAQ:WBA), these two firms form a quasi duopoly in retail pharmacy convenience. Read more...
Merger Mania: Companies Are Emboldened by Court Ruling A dive into the fundamentals of CVS and Aetna. As the companies prepare to face antitrust regulators, the markets like what they see
It’s called merger mania. Also waiting to tie the knot: Retail pharmacy giant CVS Health (NYSE:CVS) and its betrothed, heath insurer Aetna (NYSE:AET). Read more...
First Pacific Advisors' Top Picks of 1st Quarter Nine new stocks line the portfolio, mixing energy and utility stocks with the merger fervor that hit this week. Aetna forms part of its holdings
First Pacific Advisors (Trades, Portfolio) initiated a handful of major positions to top off a $31 billion portfolio in the first quarter. Read more...
Wall Street High Wednesday Premarket WSI Industries higher on earnings
The U.S. stock market advanced on Wednesday, with investors waiting for the Federal Reserve's decision on interest rates. Read more...
Research Report Identifies Aetna, Square, Overstock, INTL FCStone, Arista Networks, and Hanesbrands with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
CVS Health Announces Management Team for Combined Company Following Close of Aetna Acquisition Transaction
David Abrams' Top Buys and Sells in 1st Quarter The guru chose Houston-based midstream energy provider and sold Wells Fargo. He also dumped more shares of bookseller
The investment firm of guru investor David Abrams (Trades, Portfolio) established major positions in managed-health care giant Aetna Inc. (NYSE:AET) and one of North America's largest midstream energy suppliers, Kinder Morgan Co. (NYSE:KMI). Read more...
Jerome Dodson Buys CVS in 1st Quarter Guru also boosts one position and divests two others
Parnassus Fund manager Jerome Dodson (Trades, Portfolio) disclosed on Tuesday that he invested in CVS Health Corp. (NYSE:CVS) during the first quarter. Dodson also expanded his position in Nielson Holdings PLC (NYSE:NLSN) and divested his positions in International Business Machines Corp. (NYSE:IBM) and Wells Fargo & Co. (NYSE:WFC). Read more...

Ratios

vs
industry
vs
history
PE Ratio 18.55
AET's PE Ratio is ranked lower than
90% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.79 vs. AET: 18.55 )
Ranked among companies with meaningful PE Ratio only.
AET' s PE Ratio Range Over the Past 10 Years
Min: 5.42  Med: 12.66 Max: 45.35
Current: 18.55
5.42
45.35
Forward PE Ratio 17.61
AET's Forward PE Ratio is ranked lower than
62% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.27 vs. AET: 17.61 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 18.55
AET's PE Ratio without NRI is ranked lower than
90% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.79 vs. AET: 18.55 )
Ranked among companies with meaningful PE Ratio without NRI only.
AET' s PE Ratio without NRI Range Over the Past 10 Years
Min: 5.42  Med: 12.66 Max: 45.35
Current: 18.55
5.42
45.35
Price-to-Owner-Earnings 21.21
AET's Price-to-Owner-Earnings is ranked lower than
99.99% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.47 vs. AET: 21.21 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
AET' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.31  Med: 12.05 Max: 143.08
Current: 21.21
5.31
143.08
PB Ratio 3.71
AET's PB Ratio is ranked lower than
62% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.42 vs. AET: 3.71 )
Ranked among companies with meaningful PB Ratio only.
AET' s PB Ratio Range Over the Past 10 Years
Min: 0.88  Med: 1.83 Max: 4.05
Current: 3.71
0.88
4.05
PS Ratio 1.07
AET's PS Ratio is ranked lower than
56% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.73 vs. AET: 1.07 )
Ranked among companies with meaningful PS Ratio only.
AET' s PS Ratio Range Over the Past 10 Years
Min: 0.29  Med: 0.55 Max: 1.12
Current: 1.07
0.29
1.12
Price-to-Free-Cash-Flow 23.48
AET's Price-to-Free-Cash-Flow is ranked lower than
99.99% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.78 vs. AET: 23.48 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
AET' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.49  Med: 11.36 Max: 59.67
Current: 23.48
4.49
59.67
Price-to-Operating-Cash-Flow 20.20
AET's Price-to-Operating-Cash-Flow is ranked lower than
99.99% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.15 vs. AET: 20.20 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
AET' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.68  Med: 9.58 Max: 43.51
Current: 20.2
3.68
43.51
EV-to-EBIT 11.91
AET's EV-to-EBIT is ranked lower than
81% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.89 vs. AET: 11.91 )
Ranked among companies with meaningful EV-to-EBIT only.
AET' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.6  Med: 7.8 Max: 19.4
Current: 11.91
3.6
19.4
EV-to-EBITDA 10.64
AET's EV-to-EBITDA is ranked lower than
86% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.81 vs. AET: 10.64 )
Ranked among companies with meaningful EV-to-EBITDA only.
AET' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.1  Med: 6.9 Max: 16.1
Current: 10.64
3.1
16.1
EV-to-Revenue 1.04
AET's EV-to-Revenue is ranked higher than
52% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.01 vs. AET: 1.04 )
Ranked among companies with meaningful EV-to-Revenue only.
AET' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.3  Med: 0.6 Max: 1.1
Current: 1.04
0.3
1.1
PEG Ratio 2.50
AET's PEG Ratio is ranked lower than
85% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.35 vs. AET: 2.50 )
Ranked among companies with meaningful PEG Ratio only.
AET' s PEG Ratio Range Over the Past 10 Years
Min: 0.34  Med: 1.03 Max: 6.51
Current: 2.5
0.34
6.51
Shiller PE Ratio 33.09
AET's Shiller PE Ratio is ranked lower than
69% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 27.53 vs. AET: 33.09 )
Ranked among companies with meaningful Shiller PE Ratio only.
AET' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.39  Med: 19.43 Max: 46.04
Current: 33.09
10.39
46.04

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.02
AET's Dividend Yield % is ranked lower than
65% of the 31 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.02 vs. AET: 1.02 )
Ranked among companies with meaningful Dividend Yield % only.
AET' s Dividend Yield % Range Over the Past 10 Years
Min: 0.07  Med: 0.85 Max: 1.77
Current: 1.02
0.07
1.77
Dividend Payout Ratio 0.19
AET's Dividend Payout Ratio is ranked higher than
80% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.27 vs. AET: 0.19 )
Ranked among companies with meaningful Dividend Payout Ratio only.
AET' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.15 Max: 0.31
Current: 0.19
0.01
0.31
3-Year Dividend Growth Rate 24.80
AET's 3-Year Dividend Growth Rate is ranked higher than
75% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.40 vs. AET: 24.80 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
AET' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 171.4
Current: 24.8
0
171.4
Forward Dividend Yield % 1.03
AET's Forward Dividend Yield % is ranked lower than
86% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.33 vs. AET: 1.03 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 2.19
AET's 5-Year Yield-on-Cost % is ranked lower than
71% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.89 vs. AET: 2.19 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
AET' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.15  Med: 1.82 Max: 3.8
Current: 2.19
0.15
3.8
3-Year Average Share Buyback Ratio 2.20
AET's 3-Year Average Share Buyback Ratio is ranked higher than
75% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: -0.50 vs. AET: 2.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AET' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -10.2  Med: 0.6 Max: 8.8
Current: 2.2
-10.2
8.8

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 11.27
AET's Price-to-Tangible-Book is ranked lower than
63% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.76 vs. AET: 11.27 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
AET' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.55  Med: 3.71 Max: 23.42
Current: 11.27
0.55
23.42
Price-to-Intrinsic-Value-Projected-FCF 1.53
AET's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
87% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.08 vs. AET: 1.53 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
AET' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.23  Med: 0.71 Max: 1.9
Current: 1.53
0.23
1.9
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.39
AET's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
100% of the 9 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.02 vs. AET: 1.39 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
AET' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.76  Med: 1.16 Max: 2.76
Current: 1.39
0.76
2.76
Price-to-Median-PS-Value 1.94
AET's Price-to-Median-PS-Value is ranked lower than
83% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.19 vs. AET: 1.94 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AET' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.29  Med: 0.87 Max: 2.31
Current: 1.94
0.29
2.31
Price-to-Peter-Lynch-Fair-Value 2.84
AET's Price-to-Peter-Lynch-Fair-Value is ranked lower than
100% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.09 vs. AET: 2.84 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
AET' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.19  Med: 0.86 Max: 5.57
Current: 2.84
0.19
5.57
Price-to-Graham-Number 3.05
AET's Price-to-Graham-Number is ranked lower than
62% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.60 vs. AET: 3.05 )
Ranked among companies with meaningful Price-to-Graham-Number only.
AET' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.36  Med: 1.54 Max: 5.77
Current: 3.05
0.36
5.77
Earnings Yield (Greenblatt) % 8.40
AET's Earnings Yield (Greenblatt) % is ranked lower than
61% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.22 vs. AET: 8.40 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AET' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.1  Med: 12.8 Max: 28
Current: 8.4
5.1
28
Forward Rate of Return (Yacktman) % 10.54
AET's Forward Rate of Return (Yacktman) % is ranked lower than
75% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.01 vs. AET: 10.54 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
AET' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 6.2  Med: 19.2 Max: 32.3
Current: 10.54
6.2
32.3

More Statistics

Revenue (TTM) (Mil) $60,743.00
EPS (TTM) $ 10.62
Beta0.77
Volatility14.14%
52-Week Range $149.69 - 197.63
Shares Outstanding (Mil)327.40

Analyst Estimate

Dec18 Dec19 Dec20
Revenue (Mil $) 61,108 63,860 70,642
EBIT (Mil $) 4,726 4,545 5,915
EBITDA (Mil $) 5,171 5,052 6,481
EPS ($) 10.78 11.30 12.69
EPS without NRI ($) 10.78 11.30 12.69
EPS Growth Rate
(Future 3Y To 5Y Estimate)
12.68%
Dividends per Share ($) 1.89 1.92 2.00

Piotroski F-Score Details

Piotroski F-Score: ----
Positive ROAN
Positive CFROAN
Higher ROA yoyN
CFROA > ROAN
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}